Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-21 | 2022-03-14 | 153282 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-01-28 | 2022-03-24 | 153786 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-03-11 | 2022-03-25 | 156552 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-03-25 | 2022-04-11 | 157329 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2022-07-11 | 2022-08-22 | 164367 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-01 | 2022-10-31 | 168364 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-09 | 2022-09-30 | 169060 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2022-09-16 | 2022-11-25 | 169516 |
| APO-NADOLOL | 40MG | TABLET | Resolved | 2022-09-30 | 2022-11-20 | 170801 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-10-07 | 2022-11-04 | 171427 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-11-27 | 2022-12-23 | 175892 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2022-12-16 | 2023-01-06 | 178763 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-02 | 2023-02-23 | 183492 |
| APO-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-02-09 | 2023-02-16 | 184080 |
| APO-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184106 |
| APO-CITALOPRAM | 40MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187721 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-03-23 | 2023-04-27 | 187730 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-03-30 | 2023-08-23 | 188427 |
| APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-04-27 | 2023-05-06 | 190865 |
| APO-DOXYCYCLINE MR | 40MG | CAPSULE (IMMEDIATE AND DELAYED RELEASE) | Resolved | 2023-05-06 | 2023-06-09 | 191895 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-NIZATIDINE | 150MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1127 |
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | To be discontinued | 2018-09-07 | 2018-12-28 | 60396 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-CLINDAMYCIN | 150MG | CAPSULE | Discontinued | 2019-11-11 | 2019-11-11 | 98363 |
| APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-SOTALOL | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |